183 related articles for article (PubMed ID: 27604872)
1. A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of an ERG-driven transcriptional network.
Unnikrishnan A; Guan YF; Huang Y; Beck D; Thoms JA; Peirs S; Knezevic K; Ma S; de Walle IV; de Jong I; Ali Z; Zhong L; Raftery MJ; Taghon T; Larsson J; MacKenzie KL; Van Vlierberghe P; Wong JW; Pimanda JE
Nucleic Acids Res; 2016 Dec; 44(22):10644-10661. PubMed ID: 27604872
[TBL] [Abstract][Full Text] [Related]
2. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia.
Diffner E; Beck D; Gudgin E; Thoms JA; Knezevic K; Pridans C; Foster S; Goode D; Lim WK; Boelen L; Metzeler KH; Micklem G; Bohlander SK; Buske C; Burnett A; Ottersbach K; Vassiliou GS; Olivier J; Wong JW; Göttgens B; Huntly BJ; Pimanda JE
Blood; 2013 Mar; 121(12):2289-300. PubMed ID: 23327922
[TBL] [Abstract][Full Text] [Related]
3. Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia.
Goldberg L; Tijssen MR; Birger Y; Hannah RL; Kinston SJ; Schütte J; Beck D; Knezevic K; Schiby G; Jacob-Hirsch J; Biran A; Kloog Y; Marcucci G; Bloomfield CD; Aplan PD; Pimanda JE; Göttgens B; Izraeli S
Blood; 2013 Oct; 122(15):2694-703. PubMed ID: 23974202
[TBL] [Abstract][Full Text] [Related]
4. The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia.
Sotoca AM; Prange KH; Reijnders B; Mandoli A; Nguyen LN; Stunnenberg HG; Martens JH
Oncogene; 2016 Apr; 35(15):1965-76. PubMed ID: 26148230
[TBL] [Abstract][Full Text] [Related]
5. Disruption of a GATA2-TAL1-ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells.
Thoms JAI; Truong P; Subramanian S; Knezevic K; Harvey G; Huang Y; Seneviratne JA; Carter DR; Joshi S; Skhinas J; Chacon D; Shah A; de Jong I; Beck D; Göttgens B; Larsson J; Wong JWH; Zanini F; Pimanda JE
Blood; 2021 Oct; 138(16):1441-1455. PubMed ID: 34075404
[TBL] [Abstract][Full Text] [Related]
6. The identification of (ETV6)/RUNX1-regulated genes in lymphopoiesis using histone deacetylase inhibitors in ETV6/RUNX1-positive lymphoid leukemic cells.
Starkova J; Madzo J; Cario G; Kalina T; Ford A; Zaliova M; Hrusak O; Trka J
Clin Cancer Res; 2007 Mar; 13(6):1726-35. PubMed ID: 17325341
[TBL] [Abstract][Full Text] [Related]
7. MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferation.
Huang Y; Thoms JA; Tursky ML; Knezevic K; Beck D; Chandrakanthan V; Suryani S; Olivier J; Boulton A; Glaros EN; Thomas SR; Lock RB; MacKenzie KL; Bushweller JH; Wong JW; Pimanda JE
Leukemia; 2016 Jul; 30(7):1552-61. PubMed ID: 27055868
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia: a central role for the ETS factor ERG.
Martens JH
Int J Biochem Cell Biol; 2011 Oct; 43(10):1413-6. PubMed ID: 21664289
[TBL] [Abstract][Full Text] [Related]
9. ETS-dependent regulation of a distal Gata4 cardiac enhancer.
Schachterle W; Rojas A; Xu SM; Black BL
Dev Biol; 2012 Jan; 361(2):439-49. PubMed ID: 22056786
[TBL] [Abstract][Full Text] [Related]
10. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
Haferlach C; Bacher U; Schnittger S; Alpermann T; Zenger M; Kern W; Haferlach T
Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of the Ikzf1 locus.
Yoshida T; Landhuis E; Dose M; Hazan I; Zhang J; Naito T; Jackson AF; Wu J; Perotti EA; Kaufmann C; Gounari F; Morgan BA; Georgopoulos K
Blood; 2013 Oct; 122(18):3149-59. PubMed ID: 24002445
[TBL] [Abstract][Full Text] [Related]
12. The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia.
Coskun E; von der Heide EK; Schlee C; Kühnl A; Gökbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Leuk Res; 2011 Feb; 35(2):208-13. PubMed ID: 20570349
[TBL] [Abstract][Full Text] [Related]
13. ETS-related gene ERG expression in AML patients is significantly associated with NPM1 mutation status.
Hämäläinen M; Juvonen V; Häikiö S; Lakkala T; Johansson J; Pelliniemi TT; Salmi TT; Remes K; Kairisto V
Eur J Haematol; 2010 Oct; 85(4):361-2. PubMed ID: 20546020
[No Abstract] [Full Text] [Related]
14. Genome wide mapping of ETV6 binding sites in pre-B leukemic cells.
Neveu B; Caron M; Lagacé K; Richer C; Sinnett D
Sci Rep; 2018 Oct; 8(1):15526. PubMed ID: 30341373
[TBL] [Abstract][Full Text] [Related]
15. LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML.
Ruvolo PP; Hu CW; Qiu Y; Ruvolo VR; Go RL; Hubner SE; Coombes KR; Andreeff M; Qutub AA; Kornblau SM
EBioMedicine; 2019 Jun; 44():126-137. PubMed ID: 31105032
[TBL] [Abstract][Full Text] [Related]
16. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
Marcucci G; Maharry K; Whitman SP; Vukosavljevic T; Paschka P; Langer C; Mrózek K; Baldus CD; Carroll AJ; Powell BL; Kolitz JE; Larson RA; Bloomfield CD;
J Clin Oncol; 2007 Aug; 25(22):3337-43. PubMed ID: 17577018
[TBL] [Abstract][Full Text] [Related]
17. ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia.
Kodgule R; Goldman JW; Monovich AC; Saari T; Aguilar AR; Hall CN; Rajesh N; Gupta J; Chu SA; Ye L; Gurumurthy A; Iyer A; Brown NA; Chiang MY; Cieslik MP; Ryan RJH
Blood Cancer Discov; 2023 Jan; 4(1):34-53. PubMed ID: 36350827
[TBL] [Abstract][Full Text] [Related]
18. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.
Mandoli A; Singh AA; Prange KHM; Tijchon E; Oerlemans M; Dirks R; Ter Huurne M; Wierenga ATJ; Janssen-Megens EM; Berentsen K; Sharifi N; Kim B; Matarese F; Nguyen LN; Hubner NC; Rao NA; van den Akker E; Altucci L; Vellenga E; Stunnenberg HG; Martens JHA
Cell Rep; 2016 Nov; 17(8):2087-2100. PubMed ID: 27851970
[TBL] [Abstract][Full Text] [Related]
19. Identification of IKZF1 genetic mutations as new molecular subtypes in acute myeloid leukaemia.
Wang Y; Cheng W; Zhang Y; Zhang Y; Sun T; Zhu Y; Yin W; Zhang J; Li J; Shen Y
Clin Transl Med; 2023 Jun; 13(6):e1309. PubMed ID: 37345307
[TBL] [Abstract][Full Text] [Related]
20. Ikaros and leukaemia.
Olsson L; Johansson B
Br J Haematol; 2015 May; 169(4):479-91. PubMed ID: 25753742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
